AU4999897A - Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists - Google Patents

Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists

Info

Publication number
AU4999897A
AU4999897A AU49998/97A AU4999897A AU4999897A AU 4999897 A AU4999897 A AU 4999897A AU 49998/97 A AU49998/97 A AU 49998/97A AU 4999897 A AU4999897 A AU 4999897A AU 4999897 A AU4999897 A AU 4999897A
Authority
AU
Australia
Prior art keywords
spiroethercycloalkyl
heteroaryl
receptor antagonists
tachykinin receptor
tachykinin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49998/97A
Inventor
Philippe Durette
Ihor Kopka
Malcolm Maccoss
Sander Mills
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9702922.7A external-priority patent/GB9702922D0/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of AU4999897A publication Critical patent/AU4999897A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/10Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
AU49998/97A 1996-10-25 1997-10-22 Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists Abandoned AU4999897A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2931096P 1996-10-25 1996-10-25
US60029310 1996-10-25
GB9702922 1997-02-13
GBGB9702922.7A GB9702922D0 (en) 1997-02-13 1997-02-13 Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists
PCT/US1997/019359 WO1998017276A1 (en) 1996-10-25 1997-10-22 Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists

Publications (1)

Publication Number Publication Date
AU4999897A true AU4999897A (en) 1998-05-15

Family

ID=26310983

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49998/97A Abandoned AU4999897A (en) 1996-10-25 1997-10-22 Heteroaryl spiroethercycloalkyl tachykinin receptor antagonists

Country Status (2)

Country Link
AU (1) AU4999897A (en)
WO (1) WO1998017276A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2117538A1 (en) 2007-01-24 2009-11-18 Glaxo Group Limited Pharmaceutical compositions comprising 2-methoxy-5- (5-trifluoromethyl-tetrazol-i-yl-benzyl) - (2s-phenyl-piperidin-3s-yl-)
WO2010114896A1 (en) 2009-03-31 2010-10-07 Arqule, Inc. Substituted indolo-pyridinone compounds
CN111630051B (en) 2017-11-01 2023-12-26 百时美施贵宝公司 Olefin spiro compounds as farnesol X receptor modulators
EP3704107B1 (en) 2017-11-01 2023-04-12 Bristol-Myers Squibb Company Multicyclic compounds as farnesoid x receptor modulators
JP7264906B2 (en) 2017-11-01 2023-04-25 ブリストル-マイヤーズ スクイブ カンパニー Alkene compounds as farnesoid X receptor modulators
CA3079833A1 (en) 2017-11-01 2019-05-09 Bristol-Myers Squibb Company Bridged bicyclic compounds as farnesoid x receptor modulators
MX2020004400A (en) 2017-11-01 2020-08-06 Bristol Myers Squibb Co Spirocyclic compounds as farnesoid x receptor modulators.
AR118050A1 (en) 2019-02-15 2021-09-15 Bristol Myers Squibb Co BICYCLIC COMPOUNDS REPLACED AS MODULATORS OF THE FARNESOID X RECEIVER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9104746D0 (en) * 1991-03-06 1991-04-17 British Bio Technology Compounds
EP0635503A1 (en) * 1993-07-22 1995-01-25 Shell Internationale Researchmaatschappij B.V. Fungicidal spiroheterocyclic derivatives

Also Published As

Publication number Publication date
WO1998017276A1 (en) 1998-04-30

Similar Documents

Publication Publication Date Title
AU5440996A (en) 2-acylaminopropanamides as tachykinin receptor antagonists
AU1765695A (en) Non-peptidyl tachykinin receptor antagonists
AU3579897A (en) Fibrinogen receptor antagonists
AU1339795A (en) Non-peptide tachykinin receptor antagonists
AU3633997A (en) Chemokine receptor antagonists
AU7692996A (en) Receptor antagonists
AU8153994A (en) Non-peptide tachykinin receptor antagonists
AU1842995A (en) N-acylpiperidine tachykinin antagonists
AU4746297A (en) Vitronectin receptor antagonists
AU4343796A (en) Tachykinin antagonists
AU2143295A (en) Neurokinin receptor antagonists
EP0940391A3 (en) Quinoline derivatives as tachykinin NK3 receptor antagonists
HU9601529D0 (en) Pyrimidinedion-, pyrimidinetrion-, triazinedion-, tetrahydro-quinazolinedion- derivatives as alpha-adrenerg receptor antagonists
AU7079498A (en) Neuropeptide y receptor antagonist
AU1345697A (en) Novel integrin receptor antagonists
AU4772096A (en) Delta opioid receptor antagonists
AU2242197A (en) Benzimidzolyl neuropeptide y receptor antagonists
EP0885205A4 (en) Fibrinogen receptor antagonists
AU8673198A (en) Il-8 receptor antagonists
IL124309A0 (en) 3-azetidinylalkylpiperidines or - pyrrolidines as tachykinin antagonists
AU1698997A (en) Tocolytic oxytocin receptor antagonists
AU9185598A (en) Novel neuropeptide y receptor antagonists
IL142045A0 (en) Naphthalenecarboxamides as tachykinin receptor antagonists
IL134301A0 (en) 2-acylaminopropanamines as tachykinin receptor antagonists
AU5764298A (en) Tachykinin antagonists